Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "Duchenne Muscular Dystrophy - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering.
This clinical trial report delivers an essential overview of the current Duchenne Muscular Dystrophy (DMD) clinical trials scenario globally. It provides fundamental data on the number of trials and the average participant enrollment in key countries worldwide. Coverage includes insights on disease clinical trials segmented by region, country (specifically G7 and E7 nations), phase, status, endpoint status, and sponsor types, aiding stakeholders in making informed strategic decisions.
Central to the report are the ongoing trials featuring prominent drugs, highlighted based on the number of trials underway. Derived from a robust, proprietary Pharma - Clinical Trials database, the information is compiled from over 80 different registries, conferences, journals, and news sources globally, ensuring the data remains current through continuous updates.
The report strengthens decision-making capabilities, helping stakeholders to devise competitive strategies effectively. Please note that certain sections of this document may be adjusted based on data availability and relevance to the disease in question.
Scope
- Snapshot of the global landscape for DMD clinical trials.
- Top-level data on trials broken down by Region, Country (G7 & E7), Trial Status, Phase, Sponsor Type, and Endpoint status.
- Review of key companies engaged in these trials, detailing trial titles, phases, and statuses.
- Information on unaccomplished trials (terminated, suspended, withdrawn) with reasons provided.
- Enrollment trends analysis over the past five years.
- Includes the latest news updates from the past three months.
Reasons to Buy
- Aids in crafting investment-focused strategies.
- Identifies cost-effective, optimal locations for conducting clinical trials.
- Offers top-level analysis of the Global Clinical Trials Market to uncover key business opportunities.
- Helps in understanding the trial count and enrollment trends by country in the global therapeutics market.
- Provides a comparative analysis of completed and uncompleted trials (terminated, suspended, or withdrawn) to better predict success rates.
- Facilitates comprehensive assessment of clinical trials at global, regional, and country levels.
Key Topics Covered:
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Phase
- Clinical Trials by Trial Status
- Prominent Sponsors
- Prominent Drugs
- Latest Clinical Trials News on Duchenne Muscular Dystrophy
- Clinical Trial Profile Snapshots
- Appendix
A selection of companies mentioned in this report includes, but is not limited to:
- Sarepta Therapeutics Inc
- PTC Therapeutics Inc
- BioMarin Pharmaceutical Inc
- Nippon Shinyaku Co Ltd
- Thermo Fisher Scientific Inc
- Santhera Pharmaceuticals Holding AG
- GSK plc
- Roche Holding AG
- Italfarmaco Holding SpA
- Parexel International Corp
For more information about this clinical trials report visit https://www.researchandmarkets.com/r/mvjd1d
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
